Comparative Efficacy of Implantable Upper Airway Stimulation and Surgical Interventions for OSAImplantable Stimulation Shows Better Results for Obstructive Sleep Apnea

Sleep & breathing = Schlaf & Atmung Published August 23, 2026 Study authors: Kim Do Hyun, Jang David W, Hwang Se Hwan PubMed ↗ DOI ↗ Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

UAS provides superior AHI reduction, higher cure rates, and shorter hospital stays compared to TORS in OSA patients.

This network meta-analysis evaluated the efficacy of various treatments for moderate-to-severe obstructive sleep apnea (OSA), including implantable upper airway stimulation (UAS), transoral robotic surgery (TORS), plasma ablation tongue base reduction (PATBR), and continuous positive airway pressure (CPAP). The study analyzed primary outcomes such as changes in the apnea-hypopnea index (AHI) and secondary metrics like oxygen saturation and hospital stay duration.

Findings indicate that UAS demonstrated significantly greater AHI reductions compared to TORS. Additionally, patients receiving UAS showed improved lowest oxygen saturation levels relative to those undergoing TORS. While CPAP showed a trend toward better AHI improvement than TORS, the results did not reach statistical significance. Notably, there were no significant differences observed in Epworth Sleepiness Scale scores across treatment groups.

Regarding clinical logistics, both PATBR and UAS were associated with significantly shorter postoperative hospital stays compared to TORS. Furthermore, UAS demonstrated superior success rates and significantly higher cure rates (AHI < 5) than TORS. These findings suggest that while multiple modalities are available, UAS provides more robust objective outcomes and improved recovery timelines for patients with moderate-to-severe OSA.

How this fits prior evidence

This network meta-analysis extends the understanding of surgical and non-invasive interventions for obstructive sleep apnea (OSA). It builds upon existing evidence that CPAP does not modify exercise-derived autonomic or chronotropic responses in nonsleepy patients with CAD and OSA. While previous data established the role of CPAP, this study provides a comparative framework between multiple interventions, highlighting UAS as an effective alternative to TORS for improving AHI and oxygen saturation.

Researchers analyzed data from 758 patients with moderate-to-severe obstructive sleep apnea (OSA) to compare different treatments. The study looked at four options: implantable upper airway stimulation (UAS), transoral robotic surgery (TORS), plasma ablation tongue base reduction (PATBR), and continuous positive airway pressure (CPAP).

The findings showed that patients who received the implantable device (UAS) had significantly better reductions in their apnea index compared to those who had TORS. These patients also saw better oxygen levels during sleep and higher success rates for treatment. Additionally, both the implantable device and the plasma ablation procedure were associated with shorter hospital stays than the robotic surgery.

While CPAP showed some improvement over surgery, it was not statistically significant in this study. All treatments resulted in similar improvements in how sleepy patients felt during the day. Because this is a network meta-analysis of existing data rather than a new clinical trial, these results show a link between treatment types and outcomes but do not prove one specific method is perfect for everyone.

What this means for you:

Implantable stimulation shows better apnea reduction and shorter hospital stays than robotic surgery for sleep apnea.

Common questions

How does the implantable device compare to surgery?

The study found that the implantable upper airway stimulation (UAS) showed significantly greater reduction in the apnea-hypopnea index compared to transoral robotic surgery (TORS). It also resulted in higher success rates and a much higher cure rate for patients with moderate to severe sleep apnea.

Are there differences in recovery time between treatments?

Yes, the study found that both the implantable device (UAS) and plasma ablation tongue base reduction (PATBR) were associated with significantly shorter hospital stays than transoral robotic surgery (TORS). This suggests a faster recovery period for those choosing these specific options.

Does the treatment change how tired I feel during the day?

The study looked at the Epworth Sleepiness Scale to measure daytime sleepiness. It found that there was no significant difference in how much patients' sleepiness improved across the different treatments, including CPAP and surgical options.

Study Details

Study typeSystematic review

Sample sizen = 758

EvidenceLevel 1

PublishedJul 2026

PMID42509349

View Original Abstract ↓

PURPOSE: To compare treatment outcomes of tongue base-targeting interventions-transoral robotic surgery (TORS), plasma ablation tongue base reduction (PATBR), implantable upper airway stimulation (UAS)-and continuous positive airway pressure (CPAP) in moderate-to-severe obstructive sleep apnea (OSA) patients. METHODS: The PubMed, SCOPUS, Embase, Web of Science, and Cochrane databases were systematically searched through January 2026. A network meta-analysis was conducted to compare tongue-directed surgical procedures (TORS and PATBR), UAS, and CPAP. Outcomes included changes in the apnea-hypopnea index (AHI), Epworth Sleepiness Scale (ESS), lowest oxygen saturation, postoperative hospital stay, success rate (postoperative AHI < 20 with > 50% reduction), and cure rate (postoperative AHI < 5). RESULTS: Ten studies comprising 758 patients were included. UAS demonstrated significantly greater AHI reduction than TORS (standardized mean difference [SMD] = 1.36 [0.27-2.46]) and significantly improved lowest oxygen saturation (SMD = 1.46 [0.30-2.62]). CPAP showed greater, though not statistically significant, AHI improvement compared with TORS (SMD = 1.17 [- 0.32-2.66]). ESS improvement did not differ significantly among treatments. Both PATBR (SMD = - 1.30 [- 1.80--0.79]) and UAS (SMD = - 5.49 [- 6.65--4.33]) were associated with significantly shorter hospital stays than TORS. Success rates were higher with CPAP (odds ratio [OR] = 3.73 [1.38-10.13]) and UAS (OR = 5.58 [1.97-15.84]) compared to TORS, whereas cure rates were significantly higher with UAS (OR = 12.13 [1.98-74.50]). Ranking analysis indicated overall superiority of UAS across objective outcomes. CONCLUSIONS: UAS provides superior objective outcomes with shorter hospitalization and comparable subjective improvement, supporting its role as an effective treatment option for moderate-to-severe OSA.

Comparative Efficacy of Implantable Upper Airway Stimulation and Surgical Interventions for OSAImplantable Stimulation Shows Better Results for Obstructive Sleep Apnea

How this fits prior evidence

Common questions

Study Details

Physical Exercise Improves Inhibition and Working Memory in Substance Use Disorder Patients

Physical exercise may improve memory and focus in substance use disorder

Clinical research that matters. Delivered to your inbox.

Comparative Efficacy of Implantable Upper Airway Stimulation and Surgical Interventions for OSAImplantable Stimulation Shows Better Results for Obstructive Sleep Apnea

How this fits prior evidence

Common questions

More on Obstructive Sleep Apnea

Study Details

Physical Exercise Improves Inhibition and Working Memory in Substance Use Disorder Patients

Physical exercise may improve memory and focus in substance use disorder

Clinical research that matters. Delivered to your inbox.

Related in Physical Medicine & Rehab

From Other Specialties